Utah auditor reviewing $800K buy of anti-malarial drugs, other COVID-19 purchases
Better Utah
May 1, 2020
This article originally appeared in the Deseret News. Read it in its entirety here. SALT LAKE CITY — Utah State Auditor John Dougall confirmed Friday his office is reviewing the state’s $800,000 purchase of anti-malarial drugs — a controversial move that raised red flags from pharmacists and medical professionals, and has since been refunded. “Yes, we’re looking into it,” Dougall told the Deseret News when asked
